111 related articles for article (PubMed ID: 34843984)
1. NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells.
Dash SR; Chatterjee S; Sinha S; Das B; Paul S; Pradhan R; Sethy C; Panda R; Tripathy J; Kundu CN
Nanomedicine; 2022 Feb; 40():102502. PubMed ID: 34843984
[TBL] [Abstract][Full Text] [Related]
2. Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner.
Satapathy SR; Nayak A; Siddharth S; Das S; Nayak D; Kundu CN
Nanomedicine; 2018 Apr; 14(3):883-896. PubMed ID: 29366881
[TBL] [Abstract][Full Text] [Related]
3. Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β.
Dash SR; Das B; Das C; Sinha S; Paul S; Pradhan R; Kundu CN
Nanomedicine (Lond); 2023 Jan; 18(1):19-33. PubMed ID: 36916388
[TBL] [Abstract][Full Text] [Related]
4. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells.
Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN
Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635
[TBL] [Abstract][Full Text] [Related]
5. Near infrared-responsive quinacrine-gold hybrid nanoparticles deregulate HSP-70/P300-mediated H3K14 acetylation in ER/PR+ breast cancer stem cells.
Dash SR; Das C; Das B; Jena AB; Paul S; Sinha S; Tripathy J; Kundu CN
Nanomedicine (Lond); 2024 Mar; 19(7):581-596. PubMed ID: 38293827
[No Abstract] [Full Text] [Related]
6. Comparative and Mechanistic Study on the Anticancer Activity of Quinacrine-Based Silver and Gold Hybrid Nanoparticles in Head and Neck Cancer.
Hembram KC; Chatterjee S; Sethy C; Nayak D; Pradhan R; Molla S; Bindhani BK; Kundu CN
Mol Pharm; 2019 Jul; 16(7):3011-3023. PubMed ID: 31145852
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of Cytotoxicity and Inhibition of Angiogenesis in Oral Cancer Stem Cells by a Hybrid Nanoparticle of Bioactive Quinacrine and Silver: Implication of Base Excision Repair Cascade.
Satapathy SR; Siddharth S; Das D; Nayak A; Kundu CN
Mol Pharm; 2015 Nov; 12(11):4011-25. PubMed ID: 26448277
[TBL] [Abstract][Full Text] [Related]
8. Quinacrine induces apoptosis in cancer cells by forming a functional bridge between TRAIL-DR5 complex and modulating the mitochondrial intrinsic cascade.
Das S; Tripathi N; Preet R; Siddharth S; Nayak A; Bharatam PV; Kundu CN
Oncotarget; 2017 Jan; 8(1):248-267. PubMed ID: 27542249
[TBL] [Abstract][Full Text] [Related]
9. Nanoquinacrine caused apoptosis in oral cancer stem cells by disrupting the interaction between GLI1 and β catenin through activation of GSK3β.
Nayak A; Siddharth S; Das S; Nayak D; Sethy C; Kundu CN
Toxicol Appl Pharmacol; 2017 Sep; 330():53-64. PubMed ID: 28720477
[TBL] [Abstract][Full Text] [Related]
10. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma.
Wang J; Jia L; Kuang Z; Wu T; Hong Y; Chen X; Leung WK; Xia J; Cheng B
PLoS One; 2014; 9(6):e98885. PubMed ID: 24892421
[TBL] [Abstract][Full Text] [Related]
12. Nanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1.
Nayak A; Satapathy SR; Das D; Siddharth S; Tripathi N; Bharatam PV; Kundu C
Sci Rep; 2016 Feb; 6():20600. PubMed ID: 26846872
[TBL] [Abstract][Full Text] [Related]
13. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction.
Huang JS; Yao CJ; Chuang SE; Yeh CT; Lee LM; Chen RM; Chao WJ; Whang-Peng J; Lai GM
BMC Cancer; 2016 Mar; 16():245. PubMed ID: 27012679
[TBL] [Abstract][Full Text] [Related]
14. Evodiamine inhibits both stem cell and non-stem-cell populations in human cancer cells by targeting heat shock protein 70.
Hyun SY; Le HT; Min HY; Pei H; Lim Y; Song I; Nguyen YTK; Hong S; Han BW; Lee HY
Theranostics; 2021; 11(6):2932-2952. PubMed ID: 33456581
[No Abstract] [Full Text] [Related]
15. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
16. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
[TBL] [Abstract][Full Text] [Related]
19. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
Chou MY; Hu FW; Yu CH; Yu CC
Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]